2019

1. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure

   European Journal of Heart Failure, Vol. 21, Núm. 12, pp. 1651-1658